Pahuja, Mohit
Yerasi, Charan
Lam, Phillip H.
Hashim, Hayder
Ben-Dor, Itsik
Bernardo, Nelson L.
Satler, Lowell F.
Sheikh, Farooq H.
Najjar, Samer S.
Molina, Ezequiel J.
Waksman, Ron https://orcid.org/0000-0002-4063-9226
Article History
Accepted: 30 January 2023
First Online: 27 February 2023
Compliance with Ethical Standards
:
: This manuscript is a review of the literature and, as such, is exempt from institutional review board oversight.
: Hayder Hashim reports serving as a consultant for and receiving speaker fees from Abbott, Cardiovascular Systems, Inc., and Boston Scientific. Samer S. Najjar reports receiving grant support from Abbott and Medtronic and receiving support for attending meetings from Abbott. Ron Waksman reports serving on the advisory boards of Abbott Vascular, Boston Scientific, Medtronic, Philips IGT, and Pi-Cardia Ltd.; being a consultant for Abbott Vascular, Biotronik, Boston Scientific, Cordis, Medtronic, Philips IGT, Pi-Cardia Ltd., Swiss Interventional Systems/SIS Medical AG, Transmural Systems Inc., and Venous MedTech; receiving institutional grant support from Amgen, Biotronik, Boston Scientific, Chiesi, Medtronic, and Philips IGT; and being an investor in MedAlliance and Transmural Systems Inc. All other authors have no competing interests to declare that are relevant to the content of this article.
: This article does not contain any studies with human or animal subjects performed by any of the authors.